- Home
- RVLV vs BBIO Comparison
RVLV vs BBIO Comparison
Compare RVLV & BBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVLV
- BBIO
- Stock Information
- Founded
- RVLV 2003
- BBIO 2015
- Country
- RVLV United States
- BBIO United States
- Employees
- RVLV N/A
- BBIO N/A
- Industry
- RVLV Catalog/Specialty Distribution
- BBIO Biotechnology: Pharmaceutical Preparations
- Sector
- RVLV Consumer Discretionary
- BBIO Health Care
- Exchange
- RVLV Nasdaq
- BBIO Nasdaq
- Market Cap
- RVLV N/A
- BBIO 8.0B
- IPO Year
- RVLV 2019
- BBIO 2019
- Fundamental
- Price
- RVLV $21.37
- BBIO $45.60
- Analyst Decision
- RVLV Buy
- BBIO Strong Buy
- Analyst Count
- RVLV 15
- BBIO 14
- Target Price
- RVLV $26.20
- BBIO $58.85
- AVG Volume (30 Days)
- RVLV 1.2M
- BBIO 3.3M
- Earning Date
- RVLV 08-05-2025
- BBIO 07-31-2025
- Dividend Yield
- RVLV N/A
- BBIO N/A
- EPS Growth
- RVLV 106.68
- BBIO N/A
- EPS
- RVLV 0.71
- BBIO N/A
- Revenue
- RVLV $1,156,039,000.00
- BBIO $127,415,000.00
- Revenue This Year
- RVLV $7.71
- BBIO $102.05
- Revenue Next Year
- RVLV $7.64
- BBIO $54.69
- P/E Ratio
- RVLV $30.15
- BBIO N/A
- Revenue Growth
- RVLV 9.09
- BBIO N/A
- 52 Week Low
- RVLV $14.88
- BBIO $21.72
- 52 Week High
- RVLV $39.58
- BBIO $45.48
- Technical
- Relative Strength Index (RSI)
- RVLV 54.29
- BBIO 66.67
- Support Level
- RVLV $19.93
- BBIO $41.80
- Resistance Level
- RVLV $21.93
- BBIO $45.48
- Average True Range (ATR)
- RVLV 0.86
- BBIO 1.57
- MACD
- RVLV 0.05
- BBIO -0.01
- Stochastic Oscillator
- RVLV 71.67
- BBIO 78.42
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.